IP Library Granted Patent US 8,864,748
Granted Patent B2
US 8,864,748 · App. 12/434,475 · Granted Oct 21, 2014

Manually-actuated reduced pressure treatment system having regulated pressure capabilities

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,864,748
App. No.
12/434,475
Granted
Oct 21, 2014
Kind
B2
Abstract

A reduced pressure treatment apparatus includes a charging chamber storing a first pressure less than an ambient pressure and a regulated chamber storing a second pressure less than the ambient pressure. The first pressure is less than the second pressure. A conduit provides fluid communication between the regulated chamber and the charging chamber. A regulator member is operably associated with the conduit to prevent fluid communication through the conduit when the second pressure is less than or equal to a desired therapy pressure and to allow fluid communication through the conduit when the second pressure exceeds the desired therapy pressure.

Claims (53)

1. A reduced pressure treatment apparatus comprising:

a piston chamber having a closed end;

a piston disposed within the piston chamber and being movable between an extended position and a compressed position;

a charging chamber disposed between the piston and the closed end, the charging chamber having a first volume when the piston is in the compressed position and a second volume when the piston is in the extended position, the first volume being less than the second volume;

a biasing member between the piston and the closed end and adapted to bias the piston toward the extended position;

a valve member allowing fluid to exit the charging chamber as the piston moves toward the compressed position and preventing fluid from entering the charging chamber as the piston moves toward the extended position;

a regulated chamber fluidly coupled to an outlet port adapted for coupling to a delivery conduit;

a passage between the regulated chamber and the charging chamber; and

a regulator member to regulate fluid communication through the passage between the charging chamber and the regulated chamber;

wherein the charging chamber stores a first pressure that is less than an ambient pressure;

wherein the regulated chamber stores a second pressure that is less than the ambient pressure, the first pressure being less than the second pressure; and

wherein the regulator member comprises a valve body and a regulator spring engaged with the valve body to bias the valve body against a differential between the ambient pressure and the second pressure.

2. The apparatus of claim 1 , wherein:

the regulator member closes the passage to prevent fluid communication through the passage when the pressure in the regulated chamber is less than or equal to a desired therapy pressure; and

the regulator member opens the passage to allow fluid communication through the passage when the pressure in the regulated chamber is greater than the desired therapy pressure.

3. The apparatus of claim 1 , wherein the valve member is a seal that allows unidirectional fluid flow into the charging chamber.

4. The apparatus of claim 1 , wherein the regulator member further comprises:

a valve seat disposed adjacent the passage; and

a valve body capable of engaging the valve seat to substantially reduce fluid communication through the passage.

5. The apparatus of claim 1 wherein:

the first pressure is about −150 mm Hg; and

the second pressure is about −125 mm Hg.

6. The apparatus of claim 1 , wherein the biasing member is a piston spring.

7. A reduced pressure treatment apparatus comprising:

a charging chamber storing a first pressure less than an ambient pressure;

a regulated chamber sealed from the ambient pressure and storing a second pressure less than the ambient pressure, the first pressure being less than the second pressure;

an outlet port fluidly coupled to the regulated chamber, the outlet port adapted for fluid connection to a tissue site;

a conduit providing fluid communication between the regulated chamber and the charging chamber; and

a regulator member operably associated with the conduit to prevent fluid communication through the conduit when the second pressure is less than or equal to a desired therapy pressure and to allow fluid communication through the conduit when the second pressure exceeds the desired therapy pressure.

8. The apparatus of claim 7 further comprising an electric pump to deliver a reduced pressure to the charging chamber.

9. The apparatus of claim 7 further comprising a manually-actuated pump to deliver a reduced pressure to the charging chamber.

10. The apparatus of claim 7 , wherein the regulator member further comprises:

a valve seat disposed adjacent the conduit; and

a valve body capable of engaging the valve seat to substantially reduce fluid communication through the conduit.

11. The apparatus of claim 10 further comprising:

a spring operably associated with the valve body to urge the valve body toward an open position which allows fluid communication through the conduit.

12. The apparatus of claim 7 , wherein:

the first pressure is about −150 mm Hg; and

the second pressure is about −125 mm Hg.

13. The apparatus of claim 1 , wherein:

the valve body is adapted to engage a valve seat adjacent to the passage to substantially reduce fluid communication through the passage; and

the regulator spring is operably associated with the valve body to exert a biasing force on the valve body toward an open position, the valve body in the open position allowing fluid communication through the passage;

wherein the valve body is positioned in a closed position when the pressure within the regulated chamber is less than or equal to a desired therapy pressure; and

wherein the valve body is positioned in the open position when the pressure within the regulated chamber is greater than the desired therapy pressure.

14. The apparatus of claim 1 , further comprising a conduit fluidly coupled to the outlet port.

15. The apparatus of claim 7 , wherein the regulator member further comprises:

a valve seat disposed adjacent the conduit;

a valve body capable of engaging the valve seat to substantially reduce fluid communication through the conduit; and

a regulator spring operably associated with the valve body to exert a biasing force on the valve body toward an open position, the valve body in the open position allowing fluid communication through the conduit;

wherein the biasing force on the valve body is counteracted by a pressure within the regulated chamber;

wherein the valve body is positioned in a closed position when the pressure within the regulated chamber is less than or equal to a desired therapy pressure; and

wherein the valve body is positioned in the open position when the pressure within the regulated chamber is greater than the desired pressure therapy.

16. The apparatus of claim 7 , further comprising a second conduit fluidly coupled to the outlet port.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066436/0063 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0218 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2014
From: COULTHARD, RICHARD DANIEL JOHN; ROBINSON, TIMOTHY MARK; LOCKE, CHRISTOPHER BRIAN
To: KCI LICENSING, INC.
Reel/Frame 033606/0344 →